**Core Concept**
The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in blood pressure regulation. Renin, an enzyme released by the juxtaglomerular cells of the kidneys, initiates a cascade of reactions leading to the production of angiotensin II, a potent vasoconstrictor. Plasma renin activity (PRA) is a measure of this enzymatic activity. Antihypertensive medications that decrease plasma renin activity do so by interfering with the RAAS pathway.

**Why the Correct Answer is Right**
The RAAS pathway can be modulated by various antihypertensive agents. **Diuretics**, particularly thiazide diuretics, decrease plasma renin activity by increasing sodium delivery to the distal tubules, stimulating the macula densa to release less renin. **Beta-blockers** also decrease PRA by reducing sympathetic stimulation of the juxtaglomerular cells. **Calcium channel blockers** may decrease PRA by reducing the release of renin through their vasodilatory effects. However, **ACE inhibitors** and **ARBs** actually increase plasma renin activity by blocking the conversion of angiotensin I to angiotensin II, thereby removing the negative feedback on renin release.

**Why Each Wrong Option is Incorrect**
**Option A:** Diuretics decrease plasma renin activity by increasing sodium delivery to the distal tubules, stimulating the macula densa to release less renin.
**Option B:** Beta-blockers decrease PRA by reducing sympathetic stimulation of the juxtaglomerular cells.
**Option C:** Calcium channel blockers may decrease PRA by reducing the release of renin through their vasodilatory effects.

**Clinical Pearl / High-Yield Fact**
When choosing an antihypertensive agent, consider the potential effects on the RAAS pathway, particularly in patients with renal artery stenosis or heart failure, where RAAS activation can be detrimental.

**Correct Answer:** D. ACE inhibitors and ARBs increase plasma renin activity by blocking the conversion of angiotensin I to angiotensin II, thereby removing the negative feedback on renin release.